FDA Inspection 988104 — Eurofins BioPharma Product Testing Czech Republic s.r.o.

Eurofins BioPharma Product Testing Czech Republic s.r.o. — FEI 3008920466

The FDA completed an inspection of Eurofins BioPharma Product Testing Czech Republic s.r.o. on August 9, 2016 in Brno-Jih. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 9, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Brno-Jih (Czech Republic)